Will FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
Gesundheit & MedizinOne-Off1J
Manifold MarketsKein KYCVerifizierte AuflösungsdatenOrdentlich kalibriertWarnung zur DatenqualitätQuelldaten beeinträchtigt
Daten vom 26.10.2026, 05:51 UTC · Richtlinie pm-quality-4
Aktuelle Community-PrognoseNein 86.7%
Prognostiker
11
Fragetyp
binary
Methodik
Play-money forecasting platform
Quellentyp
Prognose
Marktdaten
Aktualisiert vor 3 Stunden
Veraltet21. Feb. 23, 20:28 UTC31. Dez. 27, 22:59 UTC
Trends
Verwandte Märkte
Verwandte Fragen als Kontext, kein Vergleich gleichwertiger Kontrakte.
Will FDA approve any mRNA vaccine against small-cell lung carcinoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against squamous cell carcinoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against melanoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028?
Manifold MarketsAny vaccine against Alzheimer's disease to be safe and effective by the end of 2027?
FutuurWill the FDA approve intismeran autogene (V940/mRNA-4157)?
KalshiRegeln
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA vaccine against non-small-cell lung carcinoma in the United States before January 1, 2028.
- This does not include emergency use authorization or other forms of limited authorization.
- Resolves NO otherwise.
